BRIEF-GSK says shingles vaccine meets primary endpoint in late-stage trial
December 18, 2014 at 07:08 AM EST
* Pivotal phase III study to assess efficacy of HZ/su, an investigational vaccine for prevention of shingles, has met its primary endpoint
